Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,797 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gastric Cancer Screening in Common Variable Immunodeficiency.
van der Poorten DK, McLeod D, Ahlenstiel G, Read S, Kwok A, Santhakumar C, Bassan M, Culican S, Campbell D, Wong SWJ, Evans L, Jideh B, Kane A, Katelaris CH, Keat K, Ko Y, Lee JA, Limaye S, Lin MW, Murad A, Rafferty M, Suan D, Swaminathan S, Riminton SD, Toong C, Berglund LJ. van der Poorten DK, et al. Among authors: ko y. J Clin Immunol. 2018 Oct;38(7):768-777. doi: 10.1007/s10875-018-0546-3. Epub 2018 Sep 15. J Clin Immunol. 2018. PMID: 30219982
Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia.
Ko Y, Kariyawasam V, Karnib M, Butcher R, Samuel D, Alrubaie A, Rahme N, McDonald C, Cowlishaw J, Katelaris P, Barr G, Jones B, Connor S, Paven G, Chapman G, Park G, Gearry R, Leong RW; IBD Sydney Organisation. Ko Y, et al. Clin Gastroenterol Hepatol. 2015 Aug;13(8):1453-63.e1. doi: 10.1016/j.cgh.2015.02.045. Epub 2015 Mar 11. Clin Gastroenterol Hepatol. 2015. PMID: 25771246
Ulcerative colitis and acute perimyocarditis.
Cho KK, Ko Y, Nilsen K, Verdon C, Femia G. Cho KK, et al. Among authors: ko y. Med J Aust. 2022 Jun 20;216(11):559-561. doi: 10.5694/mja2.51554. Epub 2022 May 23. Med J Aust. 2022. PMID: 35603738 No abstract available.
Vedolizumab has longer persistence than infliximab as a first-line biological agent but not as a second-line biological agent in moderate-to-severe ulcerative colitis: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study.
Pudipeddi A, Ko Y, Paramsothy S, Leong RW. Pudipeddi A, et al. Among authors: ko y. Therap Adv Gastroenterol. 2022 Mar 8;15:17562848221080793. doi: 10.1177/17562848221080793. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 35282607 Free PMC article.
5,797 results